483
Peter Michael, M.D.FDA 483 - Peter Michael, M.D. - June 11, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
The FDA inspected G+C Research Group in Hialeah, FL, a clinical investigator, and found significant deficiencies. Observations included the overdosing of subjects with investigational product and a failure to conduct investigations according to the approved plan. Additionally, the firm failed to maintain adequate case histories, with unassessed laboratory reports and missing source documents for multiple subjects.
Open in Dashboard
ID · aa582689-d6ff-4447-a343-19b13bbf4164